Michael P Dube Insider Profile
11 Followers
Michael P Dube, VP & CAO at Intellia Therapeutics, holds 66.89K shares in Intellia Therapeutics (Ticker: NTLA). Most recently, Michael P Dube Sold 2,641 shares of Intellia Therapeutics on Jul 06, 2026 for an estimated value of $44.32K.
Profitable Transactions
3 out of 6 Profitable Transactions
Average Return
-7.80%
Average return per transaction
Time Frame
Compare to
Insider Roles
VP & CAO
Roles that Michael P Dube holds in companies
Most Profitable Insider Trade
The most profitable trade made by Michael P Dube
Michael P Dube's Trading History
List of latest transactions for each holding click on a transaction to see Michael P Dube's performance on stock
You May Also Like
Michael P Dube insider profile FAQ
What is the percentage of profitable transactions made by Michael P Dube?
The percentage of profitable transactions made by Michael P Dube is 50%.
What is the average return per transaction made by Michael P Dube?
The average return per transaction made by Michael P Dube is -7.80%.
What stocks does Michael P Dube hold?
Michael P Dube holds: NTLA stocks.
What was Michael P Dube’s latest transaction?
Michael P Dube latest transaction was an Informative Sell of $44.32K.
What was Michael P Dube's most profitable transaction?
Michael P Dube’s most profitable transaction was an Informative Sell of NTLA stock on October 3, 2025. The return on the trade was 28.70%.
What is Michael P Dube's role in Intellia Therapeutics?
Michael P Dube's role in Intellia Therapeutics is VP & CAO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.